Volume 36, Issue 11 pp. 1567-1572

Original Article

Effect of local extension sites on survival in locally advanced maxillary sinus cancer

Satoshi Kano MD, PhD,

Satoshi Kano MD, PhD

Department of Otolaryngology–Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Search for more papers by this author

Ryuichi Hayashi MD,

Ryuichi Hayashi MD

Division of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Japan

Search for more papers by this author

Akihiro Homma MD, PhD,

Corresponding Author

Akihiro Homma MD, PhD

Department of Otolaryngology–Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Corresponding author: A. Homma, Department of Otolaryngology–Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Kita 15, Nishi 7, Kita-ku, Sapporo 060-8638, Japan. E-mail: [email protected]Search for more papers by this author

Kazuto Matsuura MD, PhD,

Kazuto Matsuura MD, PhD

Division of Head and Neck Surgery, Miyagi Cancer Center, Sendai, Japan

Search for more papers by this author

Kengo Kato MD, PhD,

Kengo Kato MD, PhD

Department of Otolaryngology–Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan

Search for more papers by this author

Kazuyoshi Kawabata MD, PhD,

Kazuyoshi Kawabata MD, PhD

Department of Head and Neck Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Search for more papers by this author

Nobuya Monden MD, PhD,

Nobuya Monden MD, PhD

Department of Otorhinolaryngology–Head and Neck Surgery, National Shikoku Cancer Center, Matsuyama, Japan

Search for more papers by this author

Yasuhisa Hasegawa MD, PhD,

Yasuhisa Hasegawa MD, PhD

Department of Head and Neck Surgery, Aichi Cancer Center, Nagoya, Japan

Search for more papers by this author

Tetsuro Onitsuka MD, PhD,

Tetsuro Onitsuka MD, PhD

Department of Head and Neck Surgery, Shizuoka Cancer Center, Shizuoka, Japan

Search for more papers by this author

Yasushi Fujimoto MD, PhD,

Yasushi Fujimoto MD, PhD

Department of Otolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Search for more papers by this author

Shigemichi Iwae MD, PhD,

Shigemichi Iwae MD, PhD

Department of Head and Neck Surgery, Hyogo Cancer Center, Akashi, Japan

Search for more papers by this author

Kenji Okami MD, PhD,

Kenji Okami MD, PhD

Department of Otolaryngology, Tokai University, Isehara, Japan

Search for more papers by this author

Takashi Matsuzuka MD, PhD,

Takashi Matsuzuka MD, PhD

Department of Otolaryngology, Fukushima Medical University, Fukushima, Japan

Search for more papers by this author

Kunitoshi Yoshino MD, PhD,

Kunitoshi Yoshino MD, PhD

Department of Otolaryngology, Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

Search for more papers by this author

Masato Fujii MD, PhD,

Masato Fujii MD, PhD

Department of Otorhinolaryngology, National Tokyo Medical Center, Tokyo, Japan

Search for more papers by this author

Satoshi Kano MD, PhD,

Satoshi Kano MD, PhD

Department of Otolaryngology–Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Search for more papers by this author

Ryuichi Hayashi MD,

Ryuichi Hayashi MD

Division of Head and Neck Surgery, National Cancer Center Hospital East, Kashiwa, Japan

Search for more papers by this author

Akihiro Homma MD, PhD,

Corresponding Author

Akihiro Homma MD, PhD

Department of Otolaryngology–Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Kazuto Matsuura MD, PhD,

Kazuto Matsuura MD, PhD

Division of Head and Neck Surgery, Miyagi Cancer Center, Sendai, Japan

Search for more papers by this author

Kengo Kato MD, PhD,

Kengo Kato MD, PhD

Department of Otolaryngology–Head and Neck Surgery, Tohoku University School of Medicine, Sendai, Japan

Search for more papers by this author

Kazuyoshi Kawabata MD, PhD,

Kazuyoshi Kawabata MD, PhD

Department of Head and Neck Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Search for more papers by this author

Nobuya Monden MD, PhD,

Nobuya Monden MD, PhD

Department of Otorhinolaryngology–Head and Neck Surgery, National Shikoku Cancer Center, Matsuyama, Japan

Search for more papers by this author

Yasuhisa Hasegawa MD, PhD,

Yasuhisa Hasegawa MD, PhD

Department of Head and Neck Surgery, Aichi Cancer Center, Nagoya, Japan

Search for more papers by this author

Tetsuro Onitsuka MD, PhD,

Tetsuro Onitsuka MD, PhD

Department of Head and Neck Surgery, Shizuoka Cancer Center, Shizuoka, Japan

Search for more papers by this author

Yasushi Fujimoto MD, PhD,

Yasushi Fujimoto MD, PhD

Department of Otolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Search for more papers by this author

Shigemichi Iwae MD, PhD,

Shigemichi Iwae MD, PhD

Department of Head and Neck Surgery, Hyogo Cancer Center, Akashi, Japan

Search for more papers by this author

Kenji Okami MD, PhD,

Kenji Okami MD, PhD

Department of Otolaryngology, Tokai University, Isehara, Japan

Search for more papers by this author

Takashi Matsuzuka MD, PhD,

Takashi Matsuzuka MD, PhD

Department of Otolaryngology, Fukushima Medical University, Fukushima, Japan

Search for more papers by this author

Kunitoshi Yoshino MD, PhD,

Kunitoshi Yoshino MD, PhD

Department of Otolaryngology, Head and Neck Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

Search for more papers by this author

Masato Fujii MD, PhD,

Masato Fujii MD, PhD

Department of Otorhinolaryngology, National Tokyo Medical Center, Tokyo, Japan

Search for more papers by this author

First published: 30 August 2013

https://doi.org/10.1002/hed.23483

Citations: 16

Share a link

Email
Wechat
Bluesky

Abstract

Background

We analyzed the effects of local extension sites on survival in patients with locally advanced maxillary sinus cancer.

Methods

The criteria for inclusion in this study were as follows: (1) previously untreated maxillary sinus cancer; (2) squamous cell carcinoma; (3) T4 disease; and (4) curative-intent treatment. The data for 118 patients were obtained from 28 institutions across Japan and analyzed for overall survival and local control rates by local extension site.

Results

Sites with a poor prognosis included the cribriform plate, dura, nasopharynx, middle cranial fossa, and cranial nerves other than V2. There was a significant correlation among these sites, except for the cranial nerves. Additionally, the hard palate was the only site that correlated with nodal involvement and showed a poor treatment outcome.

Conclusion

Even in cases presenting with similar T4 maxillary sinus cancer, treatment should be performed in consideration of the local extension site. © 2013 Wiley Periodicals, Inc. Head Neck 36: 1567–1572, 2014

REFERENCES

1 Japan Society for Head and Neck Cancer. Report of Head and Neck Cancer of Japan Clinical Statistics of Registered Patients, 2003. Jpn J Head Neck Cancer 2007; 33(Suppl): 90–96.
Google Scholar
2 Sato Y, Morita M, Takahashi HO, Watanabe N, Kirikae I. Combined surgery, radiotherapy, and regional chemotherapy in carcinoma of the paranasal sinuses. Cancer 1970; 25: 571–579.
10.1002/1097-0142(197003)25:3<571::AID-CNCR2820250312>3.0.CO;2-N
CAS PubMed Web of Science® Google Scholar
3 Nishino H, Ichimura K, Tanaka H, et al. Results of orbital preservation for advanced malignant maxillary sinus tumors. Laryngoscope 2003; 113: 1064–1069.
10.1097/00005537-200306000-00028
PubMed Web of Science® Google Scholar
4 Al-Sarraf M, Pajak TF, Marcial VA, et al. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study. Cancer 1987; 59: 259–265.
10.1002/1097-0142(19870115)59:2<259::AID-CNCR2820590214>3.0.CO;2-1
CAS PubMed Web of Science® Google Scholar
5 Merlano M, Benasso M, Corvò R, et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996; 88: 583–589.
10.1093/jnci/88.9.583
CAS PubMed Web of Science® Google Scholar
6 Paccagnella A, Orlando A, Marchiori C, et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J Natl Cancer Inst 1994; 86: 265–272.
10.1093/jnci/86.4.265
CAS PubMed Web of Science® Google Scholar
7 Kanoto M, Oda A, Hosoya T, et al. Impact of superselective transarterial infusion therapy of high-dose cisplatin on maxillary cancer with orbital invasion. AJNR Am J Neuroradiol 2010; 31: 1390–1394.
10.3174/ajnr.A2082
CAS PubMed Web of Science® Google Scholar
8 Robbins KT. The evolving role of combined modality therapy in head and neck cancer. Arch Otolaryngol Head Neck Surg 2000; 126: 265–269.
10.1001/archotol.126.3.265
CAS PubMed Web of Science® Google Scholar
9 Homma A, Oridate N, Suzuki F, et al. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience. Cancer 2009; 115: 4705–4714.
10.1002/cncr.24515
CAS PubMed Web of Science® Google Scholar
10 Bhattacharyya N. Factors affecting survival in maxillary sinus cancer. J Oral Maxillofac Surg 2003; 61: 1016–1021.
10.1016/S0278-2391(03)00313-6
PubMed Web of Science® Google Scholar
11 Airoldi M, Garzaro M, Valente G, et al. Clinical and biological prognostic factors in 179 cases with sinonasal carcinoma treated in the Italian Piedmont region. Oncology 2009; 76: 262–269.
10.1159/000206140
PubMed Web of Science® Google Scholar
12 Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001; 92: 3012–3029.
10.1002/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E
CAS PubMed Web of Science® Google Scholar
13 Carrillo JF, Güemes A, Ramírez–Ortega MC, Oñate–Ocaña LF. Prognostic factors in maxillary sinus and nasal cavity carcinoma. Eur J Surg Oncol 2005; 31: 1206–1212.
10.1016/j.ejso.2005.04.001
CAS PubMed Web of Science® Google Scholar
14 Cantù G, Bimbi G, Miceli R, et al. Lymph node metastases in malignant tumors of the paranasal sinuses: prognostic value and treatment. Arch Otolaryngol Head Neck Surg 2008; 134: 170–177.
10.1001/archoto.2007.30
PubMed Web of Science® Google Scholar
15 Morris LG, Patel SG, Shah JP, Ganly I. High rates of regional failure in squamous cell carcinoma of the hard palate and maxillary alveolus. Head Neck 2011; 33: 824–830.
10.1002/hed.21547
PubMed Web of Science® Google Scholar
16 McMahon JD, Wong LS, Crowther J, et al. Patterns of local recurrence after primary resection of cancers that arise in the sinonasal region and the maxillary alveolus. Br J Oral Maxillofac Surg 2013; 51: 389–393.
10.1016/j.bjoms.2012.09.018
PubMed Web of Science® Google Scholar

Citing Literature

Volume36, Issue11

November 2014

Pages 1567-1572

Effect of local extension sites on survival in locally advanced maxillary sinus cancer

Abstract

Background

Methods

Results

Conclusion

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Effect of local extension sites on survival in locally advanced maxillary sinus cancer

Abstract

Background

Methods

Results

Conclusion

REFERENCES

Citing Literature

References

Related

Information